https://www.therinibio.com/
Therini - Therini Bio
Jul 12, 2024 - Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
therinibio
https://www.biospace.com/press-releases/angelini-ventures-invests-into-39-million-series-a-extension-round-for-therini-bio-a-clinical-stage-company-developing-fibrin-targeting-immunotherapies-for-neurodegenerative-diseases
Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical...
https://www.globenewswire.com/fr/news-release/2025/05/14/3081286/0/en/Therini-Bio-Raises-Additional-39M-Series-A-Financing-to-Advance-Clinical-Development-of-Neurodegenerative-Disease-Pipeline.html
Therini Bio Raises Additional $39M Series A Financing to
Therini Bio raised a $39M Series A financing, bringing the Series A total to $75M, from top-tier investors to commence THN391 Ph 1b AD and DME studies...
series a financingtherinibioraisesadditional
https://www.biospace.com/therini-bio-raises-36m-series-a-financing-to-develop-fibrin-targeted-therapies-for-neurodegenerative-and-retinal-diseases
Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for...
Apr 27, 2023 - Therini Bio, Inc., a biotech company aimed at developing fibrin-targeted therapies to treat inflammatory neurodegenerative and retinal diseases, today...
series a financing